<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39440677</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1750-2659</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Influenza and other respiratory viruses</Title><ISOAbbreviation>Influenza Other Respir Viruses</ISOAbbreviation></Journal><ArticleTitle>Extrapolating Sentinel Surveillance Information to Estimate National COVID Hospital Admission Rates: A Bayesian Modeling Approach.</ArticleTitle><Pagination><StartPage>e70026</StartPage><MedlinePgn>e70026</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e70026</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1111/irv.70026</ELocationID><Abstract><AbstractText>The COVID-19-Associated Hospitalization Surveillance Network (COVID-NET) was established in March 2020 to monitor trends in hospitalizations associated with SARS-CoV-2 infection. COVID-NET is a geographically diverse population-based surveillance system for laboratory-confirmed COVID-19-associated hospitalizations with a combined catchment area covering approximately 10% of the US population. Data collected in COVID-NET includes monthly counts of hospitalizations for persons with confirmed SARS-CoV-2 infection who reside within the defined catchment area. A Bayesian modeling approach is proposed to estimate US national COVID-associated hospital admission rates based on information reported in the COVID-NET system. A key component of the approach is the ability to estimate uncertainty resulting from extrapolation of hospitalization rates observed within COVID-NET to the US population. In addition, the proposed model enables estimation of other contributors to uncertainty including temporal dependence among reported COVID-NET admission counts, the impact of unmeasured site-specific factors, and the frequency and accuracy of testing for SARS-CoV-2 infection. Based on the proposed model, an estimated 6.3 million (95% uncertainty interval (UI) 5.4-7.3 million) COVID-19-associated hospital admissions occurred in the United States from September 2020 through December 2023. Between April 2020 and December 2023, model-based monthly admission rate estimates ranged from a minimum of 1 per 10,000 population (95% UI 0.7-1.2) in June of 2023 to a highest monthly level of 16 per 10,000 (95% UI 13-19) in January 2022.</AbstractText><CopyrightInformation>Published 2024. This article is a U.S. Government work and is in the public domain in the USA. Influenza and Other Respiratory Viruses published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Devine</LastName><ForeName>Owen</ForeName><Initials>O</Initials><Identifier Source="ORCID">0009-0008-3120-2840</Identifier><AffiliationInfo><Affiliation>Eagle Global Scientific, LLC, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pham</LastName><ForeName>Huong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>CDC, National Center for Immunization and Respiratory Diseases, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gunnels</LastName><ForeName>Betsy</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>CDC, Global Health Center, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reese</LastName><ForeName>Heather E</ForeName><Initials>HE</Initials><AffiliationInfo><Affiliation>CDC, National Center for Emerging and Zoonotic Infectious Diseases, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steele</LastName><ForeName>Molly</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>CDC, National Center for Emerging and Zoonotic Infectious Diseases, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Couture</LastName><ForeName>Alexia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>CDC, National Center for Immunization and Respiratory Diseases, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iuliano</LastName><ForeName>Danielle</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-8742-3687</Identifier><AffiliationInfo><Affiliation>CDC, National Center for Immunization and Respiratory Diseases, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sachdev</LastName><ForeName>Darpun</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>California Department of Public Health, Richmond, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alden</LastName><ForeName>Nisha B</ForeName><Initials>NB</Initials><AffiliationInfo><Affiliation>Colorado Department of Public Health &amp; Environment, Denver, Colorado, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meek</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, Connecticut, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Witt</LastName><ForeName>Lucy</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-1475-6952</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases, Emory University School of Medicine, Georgia Emerging Infections Program, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Patricia A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Maryland Department of Health, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reeg</LastName><ForeName>Libby</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Michigan Department of Health and Human Services, Lansing, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lynfield</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Minnesota Department of Health, St. Paul, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ropp</LastName><ForeName>Susan L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>New Mexico Department of Health, Santa Fe, New Mexico, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barney</LastName><ForeName>Grant</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>New York State Department of Health, Albany, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tesini</LastName><ForeName>Brenda L</ForeName><Initials>BL</Initials><AffiliationInfo><Affiliation>University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shiltz</LastName><ForeName>Eli</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Ohio Department of Health, Columbus, Ohio, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sutton</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Public Health Division, Oregon Health Authority, Portland, Oregon, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Talbot</LastName><ForeName>H Keipp</ForeName><Initials>HK</Initials><AffiliationInfo><Affiliation>Vanderbilt University Medical Center, Nashville, Tennessee, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reyes</LastName><ForeName>Isabella</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Salt Lake County Health Department, Salt Lake City, Utah, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Havers</LastName><ForeName>Fiona P</ForeName><Initials>FP</Initials><AffiliationInfo><Affiliation>CDC, National Center for Immunization and Respiratory Diseases, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Influenza Other Respir Viruses</MedlineTA><NlmUniqueID>101304007</NlmUniqueID><ISSNLinking>1750-2640</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001499" MajorTopicYN="Y">Bayes Theorem</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="Y">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018571" MajorTopicYN="Y">Sentinel Surveillance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bayesian modeling</Keyword><Keyword MajorTopicYN="N">COVID‐19</Keyword><Keyword MajorTopicYN="N">Population‐based surviellance</Keyword><Keyword MajorTopicYN="N">hospitalization</Keyword><Keyword MajorTopicYN="N">sentinel surviellance</Keyword></KeywordList><CoiStatement>The findings and conclusions in this manuscript are those of the author(s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention (CDC). Meek J declares CDC funding for Connecticut Emerging Infections Program, Ryan PA declares salary support from an Emerging Infections program cooperative agreement with CDC, Reeg L declares funding from a CSTE/CDC federal grant, and Resini B declares receipt of honoraria from Merck for editorial board membership.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>16</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>16</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39440677</ArticleId><ArticleId IdType="pmc">PMC11497105</ArticleId><ArticleId IdType="doi">10.1111/irv.70026</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
CDC
, “COVID‐NET Overview and Methods,” https://www.cdc.gov/coronavirus/2019‐ncov/covid‐data/covid‐net/purpose‐methods.html.</Citation></Reference><Reference><Citation>Reed R., Chaves S., Kirley P., et al., “Estimating Influenza Disease Burden From Population‐Based Surveillance Data in the United States,” PLoS ONE 10, no. 3 (2015): e0118369, 10.1371/journal.pone.0118369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0118369</ArticleId><ArticleId IdType="pmc">PMC4349859</ArticleId><ArticleId IdType="pubmed">25738736</ArticleId></ArticleIdList></Reference><Reference><Citation>
Couture A., Iuliano D., Chang H., et al., “Estimating COVID‐19 Hospitalizations in the United States With Surveillance Data Using a Bayesian Hierarchical Model: Modeling Study,” JMIR Public Health and Surveillance
8, no. 6 (2022): e34296, https://publichealth.jmir/org/2022/6/e34296.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9169704</ArticleId><ArticleId IdType="pubmed">35452402</ArticleId></ArticleIdList></Reference><Reference><Citation>Silk B., Scobie H., Duck W., et al., “COVID‐19 Surveillance After Expiration of the Public Health Emergency Declaration―United States, May 11, 2023,” MMWR. Morbidity and Mortality Weekly Report 72 (2023): 523–528, 10.15585/mmwr.mm7219e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7219e1</ArticleId><ArticleId IdType="pmc">PMC10208372</ArticleId><ArticleId IdType="pubmed">37167154</ArticleId></ArticleIdList></Reference><Reference><Citation>
Respiratory Virus Response (RVR) United States Hospitalization Metrics by Jurisdiction, Timeseries (n.d.), https://data.cdc.gov/Public‐Health‐Surveillance/Respiratory‐Virus‐Response‐RVR‐United‐States‐Hospi/9t9r‐e5a3/about_data.</Citation></Reference><Reference><Citation>O'Halloran A., Whitaker M., Patel K., et al., “Developing a Sampling Methodology for Timely Reporting of Population‐Based COVID‐19‐Associated Hospitalization Surveillance in the United States, COVID‐NET 2020‐2021,” Influenza and Other Respiratory Viruses 17 (2023): e10389, 10.1111/irv.13089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.13089</ArticleId><ArticleId IdType="pmc">PMC9835436</ArticleId><ArticleId IdType="pubmed">36625234</ArticleId></ArticleIdList></Reference><Reference><Citation>Forbes C., Evans M., Hastings N., and Peacock B., Statistical Distributions, Fourth ed., (Hoboken, NJ: John Wiley and Sons, 2011).</Citation></Reference><Reference><Citation>Lee D., “A Comparison of Conditional Autoregressive Models Used in Bayesian Disease Mopping,” Spatial and Spatio‐Temporal Epidemiology 2 (2011): 79–89, 10.1016/j.sste.2011.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sste.2011.03.001</ArticleId><ArticleId IdType="pubmed">22749587</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelfand A. and Vounatsou P., “Proper Multivariate Conditional Auto Regressive Models for Spatial Data Analysis,” Biostatistics 4, no. 1 (2003): 11–15, 10.1093/biostatistics/4.1.11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biostatistics/4.1.11</ArticleId><ArticleId IdType="pubmed">12925327</ArticleId></ArticleIdList></Reference><Reference><Citation>
CDC Wonder: Bridged‐Race Population Estimates (n.d.) Centers for Disease Control and Prevention, https://wonder.cdc.gov/bridged‐race‐population.html.</Citation></Reference><Reference><Citation>Kruschke J., Doing Bayesian Data Analysis: A Tutorial With R and BUGS (New York, NY: Elsevier, 2001).</Citation></Reference><Reference><Citation>
CDC
(n.d.) “Guidance for Hospitals and Acute Care Facilities Reporting of Respiratory Pathogen, Bed Capacity, and Supply Data to CDC's National Healthcare Safety Network (NHSN), Appendix D,” (Updated March 2024), https://www.hhs.gov/sites/default/files/covid‐19‐faqs‐hospitals‐hospital‐laboratory‐acute‐care‐facility‐data‐reporting.pdf.</Citation></Reference><Reference><Citation>
CDC
(n.d.) “RSV‐NET Interactive Dashboard,” https://www.cdc.gov/rsv/research/rsv‐net/dashboard.html.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>